{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T22:38:15Z","timestamp":1767739095831,"version":"3.48.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2022YFF0710600"],"award-info":[{"award-number":["2022YFF0710600"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00109-025-02622-0","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T22:34:08Z","timestamp":1767738848000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the pathogenesis of NAFLD: a study of the correlation of gut microbes and metabolites in humanized mouse gut microbiota"],"prefix":"10.1007","volume":"104","author":[{"given":"Yuanzhi","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaxi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianghao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoliang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8191-5842","authenticated-orcid":false,"given":"Xing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"2622_CR1","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/s41467-024-45520-8","volume":"15","author":"W Zhang","year":"2024","unstructured":"Zhang W, Lu J, Feng L, Xue H, Shen S, Lai S, Li P, Li P, Kuang J, Yang Z et al (2024) Sonic hedgehog-heat shock protein 90beta axis promotes the development of nonalcoholic steatohepatitis in mice. Nat Commun 15:1280","journal-title":"Nat Commun"},{"key":"2622_CR2","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","volume":"6","author":"G Targher","year":"2021","unstructured":"Targher G, Tilg H, Byrne CD (2021) Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach. Lancet Gastroenterol Hepatol 6:578\u2013588","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2622_CR3","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41419-023-06095-2","volume":"14","author":"Z Mao","year":"2023","unstructured":"Mao Z, Ma X, Jing Y, Shen M, Ma X, Zhu J, Liu H, Zhang G, Chen F (2023) Ufmylation on UFBP1 alleviates non-alcoholic fatty liver disease by modulating hepatic endoplasmic reticulum stress. Cell Death Dis 14:584","journal-title":"Cell Death Dis"},{"key":"2622_CR4","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","volume":"146","author":"JE Lambert","year":"2014","unstructured":"Lambert JE, Ramos-Roman MA, Browning JD, Parks EJ (2014) Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology 146:726\u2013735","journal-title":"Gastroenterology"},{"key":"2622_CR5","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","volume":"69","author":"C Lebeaupin","year":"2018","unstructured":"Lebeaupin C, Vallee D, Hazari Y, Hetz C, Chevet E, Bailly-Maitre B (2018) Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. J Hepatol 69:927\u2013947","journal-title":"J Hepatol"},{"key":"2622_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/jcb.29311","volume":"121","author":"J Chen","year":"2020","unstructured":"Chen J, Vitetta L (2020) Mitochondria could be a potential key mediator linking the intestinal microbiota to depression. J Cell Biochem 121:17\u201324","journal-title":"J Cell Biochem"},{"key":"2622_CR7","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1097\/MEG.0000000000001506","volume":"31","author":"J Chen","year":"2019","unstructured":"Chen J, Vitetta L (2019) Bile acids and butyrate in the effects of probiotics\/synbiotics on nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 31:1475\u20131476","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2622_CR8","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2351620","volume":"16","author":"J Wei","year":"2024","unstructured":"Wei J, Luo J, Yang F, Feng X, Zeng M, Dai W, Pan X, Yang Y, Li Y, Duan Y et al (2024) Cultivated Enterococcus faecium B6 from children with obesity promotes nonalcoholic fatty liver disease by the bioactive metabolite tyramine. Gut Microbes 16:2351620","journal-title":"Gut Microbes"},{"key":"2622_CR9","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00018-019-03011-w","volume":"76","author":"Z Safari","year":"2019","unstructured":"Safari Z, Gerard P (2019) The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD). Cell Mol Life Sci 76:1541\u20131558","journal-title":"Cell Mol Life Sci"},{"key":"2622_CR10","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","volume":"13","author":"C Leung","year":"2016","unstructured":"Leung C, Rivera L, Furness JB, Angus PW (2016) The role of the gut microbiota in NAFLD. Nat Rev Gastroenterol Hepatol 13:412\u2013425","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2622_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20143586","volume":"20","author":"REM Baiden-Amissah","year":"2019","unstructured":"Baiden-Amissah REM, Tuyaerts S (2019) Contribution of aging, obesity, and microbiota on tumor immunotherapy efficacy and toxicity. Int J Mol Sci 20:3586. https:\/\/doi.org\/10.3390\/ijms20143586","journal-title":"Int J Mol Sci"},{"key":"2622_CR12","first-page":"966","volume":"36","author":"Y Zheng","year":"2015","unstructured":"Zheng Y, Hao S, Hu L, Cheng T (2015) Development of immunodeficient mice\/humanized mouse models and their applications in hematology research. Zhonghua Xue Ye Xue Za Zhi 36:966\u2013971","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"2622_CR13","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3000322","volume":"1","author":"PJ Turnbaugh","year":"2009","unstructured":"Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI (2009) The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 1:6ra14","journal-title":"Sci Transl Med"},{"key":"2622_CR14","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.24127","volume":"53","author":"EM Brunt","year":"2011","unstructured":"Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA, Network NCR (2011) Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology 53:810\u2013820","journal-title":"Hepatology"},{"key":"2622_CR15","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/hep.32475","volume":"76","author":"RK Pai","year":"2022","unstructured":"Pai RK, Jairath V, Hogan M, Zou G, Adeyi OA, Anstee QM, Aqel BA, Behling C, Carey EJ, Clouston AD et al (2022) Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity score. Hepatology 76:1150\u20131163","journal-title":"Hepatology"},{"key":"2622_CR16","doi-asserted-by":"publisher","first-page":"9923","DOI":"10.7150\/thno.45988","volume":"10","author":"Q Zheng","year":"2020","unstructured":"Zheng Q, Martin RC, Shi X, Pandit H, Yu Y, Liu X, Guo W, Tan M, Bai O, Meng X et al (2020) Lack of FGF21 promotes NASH-HCC transition via hepatocyte-TLR4-IL-17A signaling. Theranostics 10:9923\u20139936","journal-title":"Theranostics"},{"key":"2622_CR17","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/hep.24452","volume":"54","author":"R Hernaez","year":"2011","unstructured":"Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, Clark JM (2011) Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 54:1082\u20131090","journal-title":"Hepatology"},{"key":"2622_CR18","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/hep.23784","volume":"52","author":"BA Neuschwander-Tetri","year":"2010","unstructured":"Neuschwander-Tetri BA, Clark JM, Bass NM, Van Natta ML, Unalp-Arida A, Tonascia J, Zein CO, Brunt EM, Kleiner DE, McCullough AJ et al (2010) Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology 52:913\u2013924","journal-title":"Hepatology"},{"key":"2622_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.nmni.2016.12.015","volume":"16","author":"M Bilen","year":"2017","unstructured":"Bilen M, Mbogning MD, Cadoret F, Dubourg G, Daoud Z, Fournier PE, Raoult D (2017) \u201cPygmaiobacter massiliensis\u201d sp. nov., a new bacterium isolated from the human gut of a Pygmy woman. New Microbes New Infect 16:37\u201338","journal-title":"New Microbes New Infect"},{"key":"2622_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10809","volume":"482","author":"J Henao-Mejia","year":"2012","unstructured":"Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ et al (2012) Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482:179\u2013185","journal-title":"Nature"},{"key":"2622_CR21","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01155-21","volume":"12","author":"M Matsui","year":"2021","unstructured":"Matsui M, Fukunishi S, Nakano T, Ueno T, Higuchi K, Asai A (2021) Ileal bile acid transporter inhibitor improves hepatic steatosis by ameliorating gut microbiota dysbiosis in NAFLD model mice. MBio 12:e0115521","journal-title":"MBio"},{"key":"2622_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/nu16081169","volume":"16","author":"X Wang","year":"2024","unstructured":"Wang X, Jin Y, Di C, Zeng Y, Zhou Y, Chen Y, Pan Z, Li Z, Ling W (2024) Supplementation of Silymarin Alone or in Combination with Salvianolic Acids B and Puerarin Regulates Gut Microbiota and Its Metabolism to Improve High-Fat Diet-Induced NAFLD in Mice. Nutrients 16:1169. https:\/\/doi.org\/10.3390\/nu16081169","journal-title":"Nutrients"},{"key":"2622_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s40168-021-01052-7","volume":"9","author":"J Mayneris-Perxachs","year":"2021","unstructured":"Mayneris-Perxachs J, Cardellini M, Hoyles L, Latorre J, Davato F, Moreno-Navarrete JM, Arnoriaga-Rodriguez M, Serino M, Abbott J, Barton RH et al (2021) Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiome. Microbiome 9:104","journal-title":"Microbiome"},{"key":"2622_CR24","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1136\/gutjnl-2012-303816","volume":"62","author":"T Le Roy","year":"2013","unstructured":"Le Roy T, Llopis M, Lepage P, Bruneau A, Rabot S, Bevilacqua C, Martin P, Philippe C, Walker F, Bado A et al (2013) Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut 62:1787\u20131794","journal-title":"Gut"},{"key":"2622_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/nu9111220","volume":"9","author":"CC Chiu","year":"2017","unstructured":"Chiu CC, Ching YH, Li YP, Liu JY, Huang YT, Huang YW, Yang SS, Huang WC, Chuang HL (2017) Nonalcoholic fatty liver disease is exacerbated in high-fat diet-fed gnotobiotic mice by colonization with the gut microbiota from patients with nonalcoholic steatohepatitis. Nutrients 9:1220. https:\/\/doi.org\/10.3390\/nu9111220","journal-title":"Nutrients"},{"key":"2622_CR26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40168-023-01469-2","volume":"11","author":"I Bourdeau-Julien","year":"2023","unstructured":"Bourdeau-Julien I, Castonguay-Paradis S, Rochefort G, Perron J, Lamarche B, Flamand N, Di Marzo V, Veilleux A, Raymond F (2023) The diet rapidly and differentially affects the gut microbiota and host lipid mediators in a healthy population. Microbiome 11:26","journal-title":"Microbiome"},{"key":"2622_CR27","doi-asserted-by":"publisher","unstructured":"Obermuller B, Singer G, Kienesberger B, Klymiuk I, Sperl D, Stadlbauer V, Horvath A, Miekisch W, Gierschner P, Grabherr R et al (2020) The effects of prebiotic supplementation with OMNi-LOGiC((R)) FIBRE on fecal microbiome, fecal volatile organic compounds, and gut permeability in murine neuroblastoma-induced tumor-associated cachexia. Nutrients 12. https:\/\/doi.org\/10.3390\/nu12072029","DOI":"10.3390\/nu12072029"},{"key":"2622_CR28","doi-asserted-by":"publisher","first-page":"843877","DOI":"10.3389\/fphar.2022.843877","volume":"13","author":"Y Gao","year":"2022","unstructured":"Gao Y, Liu L, Li C, Liang YT, Lv J, Yang LF, Zhao BN (2022) Study on the antipyretic and anti-inflammatory mechanism of Shuanghuanglian oral liquid based on gut microbiota-host metabolism. Front Pharmacol 13:843877","journal-title":"Front Pharmacol"},{"key":"2622_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11020294","volume":"11","author":"C Campbell","year":"2023","unstructured":"Campbell C, Kandalgaonkar MR, Golonka RM, Yeoh BS, Vijay-Kumar M, Saha P (2023) Crosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and Immunotherapy. Biomedicines 11:294. https:\/\/doi.org\/10.3390\/biomedicines11020294","journal-title":"Biomedicines"},{"key":"2622_CR30","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos A, de Gottardi A, Rescigno M (2020) The gut-liver axis in liver disease: pathophysiological basis for therapy. J Hepatol 72:558\u2013577","journal-title":"J Hepatol"},{"key":"2622_CR31","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","volume":"34","author":"H Tilg","year":"2022","unstructured":"Tilg H, Adolph TE, Trauner M (2022) Gut-liver axis: pathophysiological concepts and clinical implications. Cell Metab 34:1700\u20131718","journal-title":"Cell Metab"},{"key":"2622_CR32","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41575-023-00771-6","volume":"20","author":"O Pabst","year":"2023","unstructured":"Pabst O, Hornef MW, Schaap FG, Cerovic V, Clavel T, Bruns T (2023) Gut-liver axis: barriers and functional circuits. Nat Rev Gastroenterol Hepatol 20:447\u2013461","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2622_CR33","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.numecd.2012.02.007","volume":"22","author":"D Compare","year":"2012","unstructured":"Compare D, Coccoli P, Rocco A, Nardone OM, De Maria S, Carteni M, Nardone G (2012) Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 22:471\u2013476","journal-title":"Nutr Metab Cardiovasc Dis"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02622-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-025-02622-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02622-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T22:34:09Z","timestamp":1767738849000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-025-02622-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2622"],"URL":"https:\/\/doi.org\/10.1007\/s00109-025-02622-0","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"17 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted according to the ethical policies and procedures approved by the Animal Care and Use Committee at the Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Peking Union Medical College (approval No. ZH23003).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}